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1. Introduction
During early development, human dental pulp is originated from neural crest, which is a
transient embryonic structure (Fig. 1). According to current knowledge, neural crest stem cells
(NCSCs) have the capacity to self-renewal and display a developmental potential almost the
same as embryonic stem (ES) cells (Kerkis and Caplan, 2012). These postmigratory NCSCs
generate all craniofacial bones, the majority of the peripheral nervous system cells and tissues,
as well as several non-neural cell types, such as smooth muscle cells of the cardiovascular
system, pigment cells in the skin, cartilage, connective tissue, corneal epithelium and dental
pulp among them. Although postmigratory, postnatal NCSCs are of restricted developmental
potential they maintain functional characteristics resembling their embryonic counterparts
and an ability to differentiate into a broad spectrum of cell types (Le Douarin et al., 2004, 2007,
2008; Dupin et al., 2007; Le Douarin & Dupin, 2003, 2012).
Figure 1. Early development of NCSCs. According to current knowledge, migrating neural crest cells are stem cells that
display almost the same potential as ES cells.
© 2013 Lizier et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The marathon of induced pluripotent stem cells (iPSC) started when Yamanaka in 2006, by
forcing the expression of certain pluripotent genes in fibroblasts, reversed them into a
pluripotent state similar to ES cells (Takahashi &Yamanaka, 2006). The main goal of iPSC
generation is to create patient-specific cells, which would be advantageous for cell therapy due
to immune compatibility (Ohnuki et al., 2009). Research involving the production of iPSC is
being developed around the world. Production of iPSC opens new avenues for understanding
human genetic diseases; embryogenesis and will likely have a great impact in drug screening
and toxicological tests. However, fibroblasts, which were firstly used for iPSC production,
present low efficiency and slow process of reprogramming. Moreover, these cells throughout
all life are exposed to environmental factors, which can compromise their use as genetic models
(Liu, 2008; McDevitt & Palecek, 2008; Nishikawa et al., 2008; Yu & Thomson; 2008; Zhao &
Daley, 2008; Maherali & Hochedlinger, 2008; Ooi et al., 2012). Indeed, more immature somatic
cells such as, postmigratory NCSCs, and adult stem cells isolated from young organism
showed high efficiency of reprogramming (Zouboulis et al., 2008; Muchkaeva et al., 2012).
Because of the possibility to isolate NCSCs from easily accessible tissue (e.g. baby teeth is
discarded), the dental pulp derived somatic cells have become an ideal model system to study
stem cell biology in diseases during different stages of the development (childhood, youth,
middle-aged and old) with a special focus on non-invasive source of the cells for investigation
of pediatric diseases (Kerkis & Caplan, 2012; Lizier et al., 2012).
Our group isolated and fully characterized human immature dental pulp stem cells (hIDPSC),
which is a very attractive cell type, from deciduous teeth (baby teeth) (Kerkis et al., 2006; Lizier
et al., 2012). The hIDPSC present fibroblast-like morphology, retain characteristics of adult
multipotent stem cells and express at least one of three transcription factors: Oct4, Nanog and
Sox2 (Kerkis et al., 2006; Lizier et al., 2012). We also used these cells as an alternative source
for iPSC derivation (Beltrão-Braga et al., 2011) (Fig. 2).Different research groups derived iPSC
from dental pulp fibroblasts and stem cells from young, middle aged and old patients. The
difference was observed between the protocols and efficiency of iPSC generation in all these
studies (Yan et al., 2010; Tamaoki et al., 2010; Oda et al., 2010; Beltrão-Braga et al., 2011). The
present chapter is focused on comparative investigation of the methods and efficiency of iPSC
generation from dental pulp stem cells and fibroblasts (control). Differentiation potential,
assuredness and the future perspectives of the use of these iPSC derived from dental pulp stem
cells in basic research and in biotechnology will also be broadly discussed.
2. Dental pulp somatic cells used for iPSC generation
Human dental tissues are rich in stem cells (Giordano et al., 2011; Kerkis & Caplan, 2012).
Different research groups isolated and characterized several types of stem cells used for iPSC
generation: (i) from apical papilla (Yan et al., 2010), (ii) from dental pulp of primary exfoliated
deciduous teeth (Yan et al., 2010; Beltrão-Braga et al., 2011) and (iii) from wisdom teeth
(Tamaoki et al., 2010; Oda et al., 2010). SCAP (stem cells from apical papilla) were obtained
from tissue at the apex of a tooth root (Yan et al., 2010). SHED (stem cells from human exfoliated
deciduous) and IDPSC (immature dental pulp stem cells) were derived from exfoliated
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deciduous teeth (Miura et al., 2003; Kerkis et al., 2006). DPCs (dental pulp cells) and MStCs
(mesenchymal/stromal cells) were isolated from human third molars by two independent
groups (Takeda et al., 2008; Ikeda et al., 2008). All these cell types present fibroblast-like
morphology and however differ in methods of isolation, show significant difference in
expression pattern of stem cell markers and in purity of isolated population (Yan et al., 2010;
Beltrão-Braga et al., 2011; Tamaoki et al., 2010; Oda et al., 2010).
Figure 2. iPSC technology. The iPSC production can be induced by forcing the expression of certain pluripotent genes.
2.1. Transduction and reprogramming
For reprogramming of SHED/SCAP/DPSCs, heterogeneous primary human dental stem/
progenitor cell population at passages 2 and 3 were used (Yan et al., 2010). These populations
were tested for their cell surface marker expression by flow cytometry and they were positive
for STRO-1, CD146, CD73, CD90, CD105 and negative for CD14, CD34, and CD45, showing
typical immunophenotype of mesenchymal stem cells (MSC) (Friedenstein et al., 1976; Caplan,
1991). The first study used four factor genes for reprogramming, such as c-Myc [Myc proto-
oncogene protein], Klf4 [Krüppel-like factor], Oct4 [octamer-binding transcription factor 4],
and Sox2 [(sex determining region Y)-box 2] into pLenti6.2/C-Lumio/V5-DEST vector system.
Although the cells started to present morphological changes (fibroblastic to epithelial cell-like
transition), the reprogramming process failed. Further, lentiviral vectors pSin-EF2-gene-Pur
carrying 1 of the 4 factors Lin28 [Lin-28 homolog A], Nanog (Nanog homeobox), Oct4, and
Sox2 were used and first ES-like colonies were obtained. To improve reprogramming efficien‐
cy, human genes c-Myc, Klf4, Oct4, and Sox2 were subcloned into the vector pMXs and
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produced retrovirus was used for second round of transduction. Human fibroblasts, used as
a control in this study, were not able to undergo reprogramming under proposed conditions.
Retroviruses expressing four Oct3/4, Sox2, Klf4, and c-Myc or three (without c-Myc) factors
were used for reprogramming DPCs from wisdom teeth and from human dermal fibroblasts
(HDFs), which was performed according to the methods previously described (Takahashi et
al., 2007). Another group, which used MStCs from wisdom teeth, also demonstrated successful
reprogramming of these cells with pMXs retrovirus vectors containing three human Oct3/4,
Sox2, and Klf4 factor genes (Oda et al., 2010).
IDPSC is a homogeneous population in respect of the expression of MSCs (Friedenstein et al.,
1976; Caplan, 1991) markers, such as CD73, CD105, nestin and vimentin. Within IDPSC
population, several cells also express Oct3/4 and Nanog (Kerkis et al., 2006; Lizier et al., 2012).
To reprogram IDPSC, our group used four Yamanaka’s factors (Klf4, Oct4, c-Myc and Sox2)
and previously established protocol (Takahashi et al., 2007; Beltrão-Braga et al., 2011).
2.2. Formation of ES cell-like colonies and expansion
There are several important points that should be considered when iPSC are isolated and
expanded: (i) the use of mouse embryonic fibroblasts (MEF) as a feeder layer, (ii) the efficiency
of reprogramming and (iii) the efficiency of expansion (Takahashi & Yamanaka, 2006;
Lewitzky & Yamanaka, 2007; Bilic & Belmonte, 2012). Isolation of iPSC on MEF limits the
manipulation and further clinical application of these cells. Thus, isolation and expansion of
iPSC without MEF is an important step, which avoids contamination of human cells with
animal products. Efficiency of reprogramming depends on different factor, such as gene
expression profile of cells, which were used in experiments. It has been shown that more
immature cells undergo this process more efficiently, then committed or terminally differen‐
tiated cells (Zouboulis et al., 2008; Muchkaeva et al., 2012). And finally, during reprogramming,
the cells receive different number of reprogramming factors and/or they did not respond
equally to this process, therefore multiple ES-like did not complete reprogramming or non-ES
cell-like colonies raised (Aasen et al., 2008; Marchetto et al., 2009). SHED/SCAP/DPSCs/DPCs/
MStCs-derived iPSC were obtained using MEF as a feeder layer (Yan et al., 2010; Tamaoki et
al., 2010; Oda et al., 2010). IDPSC-derived iPSC were shown to be obtained under both
conditions: feeder-free on matrigel-coated dishes and on MEF (Fig. 3) (Beltrão-Braga et al.,
2011). It seems that time-course of reprogramming of different cell types varied in accordance
with age of cell donor, cell type and number of factors used. Thus, SHED/SCAP/DPSCs-
derived iPSC, showed the formation of the first colonies ~2-3 weeks after gene transduction.
DPCs-derived iPSC were reprogrammed in ~14 days, when 4 factors were used and in ~ 20-25
days, when reprogramming was performed with only 3 factors. MStCs-derived iPSC were
reprogrammed in ~25 days, while IDPSC-derived iPSC demonstrated the formation of first
colonies at ~ day 5-11. All studies demonstrated that efficiency of iPSC derivation from dental
pulp tissues is higher than that from human dermal fibroblast and primary gingival fibroblasts
(Yan et al., 2010; Tamaoki et al., 2010; Oda et al., 2010; Beltrão-Braga et al., 2011). Because the
MStCs were a heterogeneous cell population, Oda and co-authors (2010) additionally used
clonally expanded MStCs in reprogramming experiments. They observed that reprogramming
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efficiency in clonally expanded MStCs was higher and it correlates with cell proliferative
ability. The clones, which showed higher proliferative ability, demonstrated a rate of reprog‐
ramming ~ 30–100-fold higher than HDFs and ~ 7-fold higher than clones with lower prolif‐
erative ability. The IDPSC also present high reprogramming efficiency and no difference was
observed between the cells from both donors. Therefore, difficulties in reprogramming SHED/
SCAP/DPSCs can be related with cell heterogeneity of original populations (Yan et al., 2010).
Figure 3. hIDPSC-derived iPSC. (A) Representative figure of morphological characteristics of hIDPSC in vitro culturing
(light microscopy). (B-D) iPSC derivations were shown to be obtained under both conditions: feeder-free, on matrigel-
coated dishes (B and C) and on MEF (D).
Furthermore, the aging process influences all organs, tissues and cells of organism. The studies
showed that this factor is also important for cells reprogramming (Zouboulis et al., 2008; Banito
et al., 2009). SHED/SCAP/DPSCs/DPCs/MStCs/IDPSC were isolated from young donors of
variable ages 7, 10, 12, 13, 14 16, 19, 20 and 24 years old. The difference in efficiency of iPSC
generation was observed between MStCs isolated from third molars of 10-, 13-, and 16-year-
old donors. More efficient reprogramming was observed when MStCs from the 10-year-old
donor were used. Similar observation was made by Tamaoki and co-wokers (2010). In our
study we used IDPSC from 7 years old donors and we observed rapid and efficient reprog‐
ramming in both cell populations.
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2.3. Provirus integration
Viral vectors are commonly used to deliver genetic material into cells, which can be performed
in vivo (living organism) or in vitro (cell culture). Delivery of genes by a virus is efficient,
however with respect to safety, it is ideal not to use lentivirus and retrovirus vectors, since
they can integrate into the host DNA. As opposed to lentiviruses and retroviruses, adenoviral
DNA does not integrate into the genome and are considered to be safer (Tamaoki et al., 2010).
All studies performed with stem cells of dental tissue origin used lentivirus and/or retrovirus
vectors for reprogramming. Yan and co-workers (2010) examined the presence of transgenes
in the genome of iPSC clones isolating genomic DNA and generating primers specific for each
transgene. They showed that the 4 factors were all integrated into the genome of the transduced
SHED/SCAP/DPSC-iPSC. Other study, which used MStCs from wisdom teeth for reprogram‐
ming, did not provide any records about viral vectors integration (Tamaoki et al., 2010), while
another group demonstrated retroviral silencing (Oda et al., 2010). Beltrão-Braga and co-
authors (2011), which used retroviral vector for reprogramming, showed the lack of transgene
expression by RT-PCR analyses in iPSC-derived from IDPSCs.
2.4. Characterization of SHED/SCAP/DPSCs/DPCs/MStCs/IDPSC-derived iPSC
2.4.1. Expression of pluripotent stem cell markers
As expected in all studies, the iPSC obtained from tissues of dental origin, which showed ES-
like cells morphology, express key markers of pluripotent stem cells in an appropriate manner.
Immunofluorescence study demonstrates uniform expression of these antigens in iPSC
colonies derived from different types of dental stem cells. Transcription factor proteins as
Oct3/4, Nanog, Sox2 demonstrate nuclear localization, while cell surface markers, such as stage
specific embryonic antigen (SSEA) 3 and SSEA4, as well as cell surface antigens of human
embryonic carcinoma cells (TRA-1-60 and TRA-1-81) show cell surface localization. Appro‐
priate expression of transcription factors Klf4, c-Myc, Lin28, that were part of the transgene
used for reprogramming, also was observed (Yan et al. 2010; Tamaoki et al., 2010; Oda et al.,
2010; Beltrão-Braga et al., 2011) (Fig. 4).
2.4.2. Expression of molecular markers of pluripotent stem cells
Only one study performed quantitative PCR analysis before and after reprogramming for
endogenous expression of Oct4, Nanog and Sox2 genes and compared the expression level of
all these genes with those in pluripotent human ES cells. Albeit we revealed a tendency for
increasing of expression of pluripotent factors Oct4, Nanog and Sox2, when compared to non-
reprogrammed cells (18%, 1% and 2%, respectively), it was significantly lower 20% (Oct4), 10%
(Nanog) and 40% (Sox2) in comparison with human ES cells (100% - Oct4, Nanog, Sox2)
(Beltrão-Braga et al., 2011). Other studies did not provide any data about expression of these
key markers in SHED/SCAP/DPSCs/DPCs/MStCs – derived iPSC in comparison with ES cells
(Yan et al., 2010; Tamaoki et al., 2010; Oda et al., 2010). However, Oda and colleagues (2010)
demonstrated that expression levels of Oct4, Nanog, Sox2, Klf4, c-Myc, Lin28 and P53 was
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higher in iPSC derived from clonally isolated MStCs, when compared with parental cell lines,
iPSC-derived from these lines and HDFs, used as a control.
Figure 4. Expression of Oct3/4, Nanog, Sox2 and TRA-1-81 proteins in two lineages of hIDPS-IPSC five days after trans‐
duction with four factors. In A-C3,G) hIDPS-IPSC1 and D-F3,H) hIDPS-IPSC2 are presented, both showing multiple small
colonies, which already express hallmarks of pluripotent cells, such as, A-A3) and D-D3) Oct3/4; B-B3) and E-E3)
Nanog, C-C3) and F-F3) Sox2; G) and H) TRA-1-81, respectively. Nucleus stained with DAPI (blue). Note, that Oct3/4,
Nanog, Sox2 present nuclear, while TRA-1-81 presents cytoplasm localization. Several cells, which did not present ex‐
pression of these proteins and served as a control, are indicated by white arrows. Confocal Microscopy: A-F) Differen‐
tial interference contrast (DIC); A1-F1 and A2-F2) Fluorescent microscopy (Fm); A3-F3, G, H) DIC+Fm. Scale Bars: A-D3,
F-F3, H =50μm; E-E3,G=100μm.
Yan et al., (2010) quantified by real-time PCR the expression levels of endogenous Klf4 and c-
Myc. Klf4 showed relative higher expression in DPC lines than in HDFs, however lower than
in ES cells. Endogenous c-Myc expression in most DPC lines was also slightly higher than that
in HDFs and in a few iPSC clones were close to ES cells. In contrast, Oda et al., (2010) observed
low expression of Klf4 in high reprogramming cells, which was unexpected, once Klf4 is a
reprogramming factor. Yan et al., (2010) showed that endogenous Klf4 expression level
determined by real-time PCR did not completely correlate with the reprogramming efficiency
of each DPCs (wisdom teeth) line. It is noteworthy that highly expression of KLF4 was
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previously reported in senescent cells and terminally differentiated cells (Shields et al., 1996;
Conkright et al., 1999). Taken together, these data suggest that endogenous Klf4 expression
may not be the single factor in charge for the reprogramming efficiency to MSCs derived from
wisdom teeth.
2.4.3. Searching for new factors of reprogramming
Oda et al., (2010) tried to find the additional unknown factor(s) that could help in the cell
reprogramming. They focused their study on practically two genes: PAXIP1 (or PTIP) and
PARP. PAXIP1 acts as component of a histone H3 lysine four (H3K4) methyltransferase
complex (Cho et al., 2007; Patel et al., 2007) and has a role in DNA double-strand break repair
(van Attikum and Gasser, 2009). It was demonstrated that efficient reprogramming of
pluripotent gene (Oct3/4, Sox2) expression is associated with H3K4 methylation in mouse
somatic cell nuclei transplantation into amphibian oocytes (Murata et al., 2010). The expression
of this gene was about 30% more in the high reprogramming cells than in low reprogramming
as well as 3–4 times more in iPSC when compared with each parental cell line. PARP-1 belongs
to PARP family being the most abundant member and is responsible for > 85% of nuclear PARP
activity modifying histone structure through DNA-dependent “PARylation”. Higher expres‐
sion of PARP-1 was also seen after induction of reprogramming in cells derived from wisdom
teeth. The authors supposed that due to possible conformational change of chromatin by
direct/indirect actions of chromatin modification proteins such as PAXIP1 and possibly
PARP-1, high iPSC generation clones may be accessible for reprogramming factors. However,
further investigation is needed to illuminate the iPSC reprogramming mechanisms using these
genes.
2.4.4. Methylation status of cytosine guanine dinucleotides (CpG)
The methylation status of CpG in the promoter regions of Nanog and Oct4 was examined using
bisulfite DNA sequencing method in two studies (Yan et al., 2010; Oda et al., 2010) and of
Nanog in one study (Tamaoki et al., 2010). They showed that parental MStCs from wisdom
teeth were highly (Oct3/4) or partially (Nanog) methylated and the iPSC-derived from these
cells were highly unmethylated, suggesting that these promoters were active after cells
reprogramming. In contrast, the analysis of iPSC clones derived from DPSCs (wisdom teeth)
and SHED (deciduous teeth) showed that Nanog promoter had similar or slightly higher
number of methylated sites, than their non-transduced counterparts. The SHED-/DPSC-iPSC
had less methylated sites of Oct3/4 promoter than the non-transduced cells (Yan et al., 2010).
2.4.5. Telomerase activity
Telomerase activity is known to be highly activated in ES cells in order to maintain the
integrity of chromosome structure. After reprogramming, SHED- (deciduous teeth) SCAP-,
and DPSC (wisdom teeth) - iPSC showed telomerase activity very close to ES cells and a
lot  more in comparison to their  non-transduced counterparts  (Yan et  al.,  2010).  Parental
DPSCs (wisdom teeth) showed low telomerase activity whereas in each iPSC telomerase
activity was high (Oda et al., 2010).
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2.4.6. Karyotype analysis of dental stem cell-derived iPSC
Karyotype study has been performed by all authors and demonstrated that karyotype of
reprogrammed cells remained unchanged (Fig. 5). Overall, during reprogramming of stem cell
from dental pulp, numerical and gross structural chromosomal abnormalities were not
detected (Yan et al., 2010; Tamaoki et al., 2010; Oda et al., 2010; Beltrão-Braga et al., 2011).
Figure 5. Representative figures of karyotype analysis of both hIDPSC and hIDPS-iPSC: Routine Giemsa staining did
not reveal any numerical changes in chromosome number (A and B) and any chromosomal structural changes (B).
Magnification 63X. Differential interference contrast (DIC)
2.5. Differentiation of SHED/SCAP/DPSCs/DPCs/MStCs/IDPSC-iPSC
2.5.1. Embryoid body formation and in vitro differentiation
Similar to human ES cells, iPSC require the formation of embryoid bodies (EB) in order to
undergo  in  vitro  differentiation  into  various  cell  types.  All  studies  confirm  successful
differentiation of iPSC-derived from different types of dental stem cells into all three germ
layers (Yan et al.,  2010; Tamaoki et al.,  2010; Oda et al.,  2010; Beltrão-Braga et al.,  2011).
As expected, the majority of iPSC formed EBs with cystic cavities. The histological analysis
demonstrates that EBs differentiated into different cell  types of ectodermal, mesodermal,
or  endodermal  origin,  which  was  demonstrated  using  antibodies  against  specific  pro‐
teins,  which  is  expressed  in  each  of  three  germ  layers.  It  has  been  shown  that  after
reprogramming, cells tend to maintain their original commitment. Dental pulp stem cells
are  multipotent  stem  cells  derived  from  neural  crest  and  they  showed  strong  commit‐
ment into neural lineages. Therefore, neural differentiation is widely presented in all iPSC-
derived from different  types of  dental  stem cells.  Under appropriate  neurogenic culture
medium,  the  EBs  developed  into  the  cells  with  neural-like  morphology  (Fig.  6),  which
express  such markers  as  nestin,  β-tubulin  III  (TUJ1),  neuron-specific  Enolase  (NSE)  and
glial fibrillary acidic protein (GFAP) (Fig. 6).
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Figure 6. Representative figure of in vitro differentiation of hIDPS-iPSC. A) EBs adherent on Petri dish showing differ‐
entiation into neural-like cells after culturing in neurobasal+B27 medium. B) Same as in (A) showing neural-like cells in
high magnification. C) Neural-like cells present positive immunostaining with anti-nestin antibody. D) positive immu‐
nostaining with anti-TUJ1 antibody. E) Neuron-specific enolase positive immunostaining (green) in hIDPS-iPSC derived
neuronal cells. F) Morphological presentation of glial-like cells derived from hIDPS-iPSC. Positive immunostaining for
(F) anti-GFAP antibody in glial-like cells. Nucleus stained with DAPI (blue). A, B= Differential interference contrast (DIC).
C-E=Epi. F= DIC+Epi. Scale Bars: A-F=20μm.
2.5.2. Teratoma formation
To test the pluripotency, iPSC were injected into the testis or intramuscularly into the right
and/or  left  hind  leg  of  severe  combined  immunodeficient  (SCID)  mouse.  Teratomas
formation by SHED/SCAP/DPSCs/DPCs/MStCs–iPSC occurs of nine to eleven weeks after
injection and histological examination of the tumor shows representative tissues of three
embryonic germ layers, such as gut-like epithelium (endoderm), cartilage (mesoderm), and
neuroepithelial rosettes (ectoderm) (Yan et al., 2010; Tamaoki et al., 2010; Oda et al., 2010).
Teratomas obtained from IDPSC-iPSC were formed between 5 and 7 weeks after reprog‐
rammed cells injection. The mice injected with parental IDPSC, as expected, did not form
teratomas.  We observed that teratomas were composed by tissues originated from three
primary  germ  layers.  Histological  characterization  of  tumor  masses  showed  that  these
teratomas includes ectodermal: primitive neural tissues, including neural tube and neural
rosettes  and  retinal  epithelium;  mesodermal:  muscle-like  cells  and  gromerulus-like
structures  and  endodermal  tissues:  respiratory  or  gastro-intestinal-like  epithelium  and
glandular-like tissue formation (Fig. 7). Similar to in vitro differentiation, teratomas derived
from  IDPSC-iPS  cells,  display  strong  neuronal  commitment  forming  rosette-,  neuro‐
sphere-  and  neural  tube-like  structures.  Neuron-specific  enolase,  which  is  a  marker  of
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neurons  and  peripheral  neuroendocrine  tissue,  and  synaptophysin  (a  synaptic  vesicle
glycoprotein),  which is found in neuroendocrine cells as well  as virtually in all  neurons
that  participate  in  synaptic  transmission  in  the  brain  and  spinal  cord  are  expressed  in
neuronal cells produced by IDPSC-iPSC in teratomas (Beltrão-Braga et al., 2011).
Figure 7. HE stained differentiated tissues from hIDPS-iPSC teratoma seven weeks after transplantation into nude
mice right limb. A) Morphogenesis observed during differentiation of hIDPS-iPSC: glomerulus-like structure formation,
with Bowman’s capsule and convoluted tubule–like structures. B) Cartilage and in (C) Condrocytes-like cells (higher
magnification). D) Respiratory-like epithelium. E) Gastrointestinal-like epithelium. F) Neural tubes-like structures. G)
Blood vessel. H) Adipose-like tissue. Magnifications: A, C) 100x, B, D-G) 20x, Scale Bar (H) = 200μm.
2.6. HLA typing
Tamaoki and co-wokers (2010) determined the human leukocyte antigens (HLA) types of 107
dental pulp cells lines in the Japanese population and identified 2 cell lines with homozygous
HLA types at all 3 loci (A, B, and DR) examined. They showed that in the Japanese population
the frequencies of haplotypes of these 2 homozygous cell lines were estimated to be 8.7% and
1.5%, data provided by the Japanese Red Cross Society (http://www.bmdc.jrc.or.jp/stat.html).
Using these frequencies, the coverage rate for a perfect match of iPSC lines, which were
established from these 2 lines was calculated. The authors showed that iPSC lines established
from these 2 homozygous cell lines would cover 16.6% and 3.0% of the Japanese population,
respectively, which corresponds to approximately 20% of the Japanese population.
2.7. SHED/SCAP/DPSCs/DPCs/MStCs/IDPSC-iPSC bank and therapeutic use
One of the major challenge of pluripotent stem cells use in cell therapies is an immune-
mediated rejection after transplantation. Today, this problem can be overcome by direct
reprogramming of patients somatic cells and by creating an iPSC bank consisting of various
HLA types thus providing therapeutic tool for the patients, which need cell transplantation
free from immune-mediated rejection. Two works reported that the establishment of 50 unique
stem cells lines, having homozygous alleles of the 3 HLA loci (A, B, and DR), would cover ~
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90% of the Japanese population with a faultless match of these loci (Nakajima et al., 2007;
Nakatsuji et al., 2008). Considering that iPSC derivation is a time consuming process and of
elevated cost, it should be necessary for cell therapies and regenerative medicine to establish
iPSC banks with a sufficient collection of HLA types, thus avoiding additional costs which are
required for iPSC production for each individual patient.
2.7.1. Requirements of iPSC generation
In spite of optimistic prognosis in respect of how many iPSC should be produced in order
to  satisfy  their  immunological  matching  within  definite  human  population,  several
requirements  must  be  challenged  before  establishing  iPSC  bank.  The  principal  require‐
ment is a method of reprogramming, which should be safe. Therefore, three major concerns
exist in the current reprogramming strategies for clinical applications: (i) the low reprog‐
ramming efficiency of human somatic cells  makes it  difficult  to generate patient-specific
iPSC, when a small amount of the cells of the patient is used; (ii) carcinogenesis may be
caused by genomic integration of  retro-  or  lentiviral  fragments into host  DNA; and (iii)
Myc  is  an  oncogene,  which  after  reactivation  might  cause  malignant  tumor  formation.
Whereas  iPSC  can  be  generated  by  three  transcription  factors  (Oct3/4,  Sox2,  and  Klf4)
without  Myc,  reprogramming  efficiency  are  significantly  reduced.  Although,  several
methods of  iPSC generation without viral  integration have been reported;  their  efficien‐
cies are extremely low in comparison with viral vectors used for induction of reprogram‐
ming (Okita et al., 2008; Stadtfeld et al., 2008; Fusaki et al., 2009; Kaji et al., 2009; Kim et
al., 2009; Soldner et al., 2009; Woltjen et al., 2009; Yu et al., 2009; Yusa et al., 2009; Zhou
et al.,  2009).  Next important issue is  availability of  donor cells,  which can provide high
efficiency in the generation of non-integrated human iPSC. Therefore, source of the cells
also  makes  its  own  demand,  such  as,  it  should  be  easily  accessible  with  minimum
discomfort for the patient, the procedure of stem cell isolation should be non-invasive, the
tissue should be easily processed, the cells should be rapidly proliferating and produced
in  sufficient  quantities,  these  cells  should  be  young  and  collected  from  healthy  volun‐
teers. Furthermore, the possibility of genetic abnormalities in donor cells due to ultravio‐
let (UV) irradiation should be minimized and finally, these cells would be able to be stored
in liquid nitrogen for a long time without the loss of their prime characteristics.
Dental pulp stem cells from deciduous and wisdom teeth are an ideal source that meets
the majority of  aforementioned requirements.  The loss  of  baby (deciduous)  teeth occurs
naturally and they can be removed with minimal discomfort to the patient during a routine
visit to the dentist, in many clinics, as well as wisdom teeth. We also showed that not only
cells, but also dental pulp can be cryopreserved and new cells can be obtained later, after
thawing  (Lizier  et  al.,  2012).  Therefore,  frozen  dental  pulp  does  not  require  in  vitro
cultivation  in  order  to  produce  the  cells  of  donor  until  he  needs  these  cells  for  iPSC
production  and/or  clinical  treatment.  Additionally,  several  dental  pulps  from  the  same
individual can be cryopreserved. This elevates a probability of successful MSCs isolation
in high quantities. These cells are safer, once they can be used by first and second degree
relatives and within all family (Kerkis and Caplan, 2012; Lizier et al., 2012).
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2.7.2. Perspectives of iPSC therapeutic use
Currently,  iPSC are  used to  understand human diseases,  including Alzheimer's  disease,
Parkinson's  disease,  cardiovascular  disease,  diabetes,  and  amyotrophic  lateral  sclerosis
(ALS), to develop and screen bioactive molecules - candidate to therapeutic drugs and to
identify molecules or genes implicated in tissue regeneration. These in vitro studies enable
researchers  to  understand  fundamental  principles  of  iPSC  function  and  differentiation,
which further will provide knowledge, necessary for therapeutic use of iPSC. Based on this
knowledge multiple pre-clinical and clinical protocols will  be produced optimizing iPSC
transplantation  in  diverse  animal  and  human  diseases  thus  becoming  a  tool  in  cell-
replacement therapy. Therefore, iPSC in the future may have tremendous clinical poten‐
tial when highly efficient and safe protocols of generation of reprogrammed stem cells will
be  developed.  Increasing our  understanding of  the  molecular  mechanisms that  underlie
reprogramming,  we  will  be  able  to  identify  the  cell  types  and  methods  of  reprogram‐
ming, which will minimize DNA alterations, and conditions of iPSC cultivation that will
allow widespread use of these cells in clinic. The scientists, however, should answer the
question  if  iPSC  are  truly  equivalent  to  human  ES  cells.  Although  iPSC  potential  for
regenerative medicine is great, our current knowledge about iPSC variability, and utility
must also increase greatly before iPSC became a standard tool for regenerative medicine.
3. Final considerations
Different dental tissues, which include apical papilla, primary exfoliated deciduous and
permanent teeth, as well as wisdom teeth were used to derivate iPSC. The data obtained by
different authors indicate that these tissues can be easily isolated and MSCs cells in sufficient
quantities can be obtained. MSCs in vivo are reversibly arrested cells, which are localized in
their niches maintaining their temporarily quiescent state. They differ from terminally
differentiated cells by developmental path that involves a set of increasingly committed stages
of specialization. The fact that these cells are undifferentiated cells suggests that their reprog‐
ramming will occur more easily than that of terminally differentiated cells. Indeed, all studies
demonstrated that in SHED/SCAP/DPSCs/DPCs/MStCs/IDPSC the reprogramming process
occurs more easily than in human fibroblasts used as a control, under the similar protocols
and vectors used for transduction, which showed to be efficient. It was also possible to
reprogram MSCs from wisdom teeth using only three factors (without c-Myc) avoiding future
implications with potential risks of oncogene use (Yu et al., 2007). For the clinical applications
of stem cells xenogeneic reagents pose the risk of a severe immune response, and the trans‐
mission of viral or bacterial infections, prions, and unidentified zoonosis. We demonstrated
that isolation of IDPSC-iPSC can occur under feeder-free conditions on matrigel-coated dishes.
Clinical stem cell therapy trials are ongoing, which request a strong focus on the safety and
quality of in vitro expanded stem cell transplants. By replacing xenogeneic products with a
defined xeno-free medium, the safety and quality of the cells with therapeutic potential may
be enhanced significantly. Similar to human ES cells, dental MSCs derived iPSC form compact
colony and retain immortal growth characteristics in culture. They express markers charac‐
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teristic of pluripotency including Nanog, Oct-4, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, exhibit
high telomerase activity and have stable karyotype. Controversies were observed in methyl‐
ation status of CpG in the promoter regions of Nanog and Oct4 in dental tissue derived iPSC.
Thus iPSC-derived from MStCs from wisdom teeth have their promoters of Oct4 and Nanog
highly unmethylated after reprogramming (Yan et al., 2010; Oda et al., 2010). The SHED-/
DPSC-iPSC had less methylated sites of Oct4 promoter than the non-transduced cells (Yan et
al., 2010). What ensues at the molecular level during the reprogramming process, however, is
not fully understood and is the current focus in iPSC research (Amabile and Meissner, 2009).
Furthermore, dental tissue derived iPSC exhibits differentiation potential like human ES cells
and can differentiate in vitro and in vivo into cells of all three primary germ layers (Takahashi
et al., 2007; Yu et al., 2007).
In cell types with endogenously expression of one or more of the factors that induce pluripo‐
tency, such as neural cells that strongly express Sox2, pluripotency may be induced more easily
or even with only a subset of factors (de Souza, 2010). In accordance, we observed that in
hIDPSC, which express these factors, but at low level, the reprogramming was speedier, when
compared with other dental tissue derived stem cells. During reprogramming, the integration
the 4 factors into the genome of the transduced SHED/SCAP/DPSC-iPSC occurred (Yan et al.,
2010). Currently, the nonintegrating reprogramming approaches, which include adenoviruses,
plasmid- and episomal vector-based methods, and delivery of reprogramming factors directly
as proteins have been developed. Additionally, other factors have been identified that can
substitute the four Yamanaka’s traditional transcription factors. Thus, Klf227 and Klf5 can
replace Klf4, Sox1 and Sox3 can replace Sox2, and n-Myc and I-Myc can replace c-Myc
(Nakagawa et al., 2008). Nr5a2 (Nuclear receptor subfamily 5, group A, member 2) can be used
to substitute Oct-4 in the reprogramming of murine somatic cells (Heng et al., 2010). Some
small molecules as the histone deacetylase inhibitor valproic acid can replace Klf4 and c-Myc
for reprogramming human fibroblasts (Huangfu et al., 2008; Lin et al., 2009).
The creation of patient-specific  stem cell  lines is  relevant for the study of basic biology,
molecular mechanisms of various diseases, for drug discovery and for treating a number
of human degenerative diseases without evoking immune rejection. HLA typing of DPC
lines (Tamaoki et al.,  2010) is of extreme importance because allows to limit the number
of  human  iPSC,  which  should  be  obtained  for  each  definite  human  population,  thus
avoiding unnecessary elevated costs of iPSC for cell therapies and regenerative medicine.
So far, human iPSC have been used for the study of the reprogramming process itself and
establishment of disease-specific cell lines and the differentiation of these cell lines into the
different cell  types affected by the disease, such as, spinal motor neurons, dopaminergic
neurons  and  cardiomyocytes  derived  from  patients  suffering  from  amyotrophic  lateral
sclerosis  (Dimos  et  al.,  2008),  spinal  muscular  atrophy  (Ebert  et  al.,  2009),  sporadic
Parkinson’s  disease (Soldner et  al.,  2009).  Exploration of  iPSC is  still  in  its  infancy,  and
understanding the  true  potential  of  these  cells  requires  continued research,  comprehen‐
sion and profound comparisons with human ES cells.
Pluripotent Stem Cells144
Acknowledgements
The authors thank Dr. Alysson Muotri from University of California San Diego, Dr. Patricia
Beltrao-Braga and Dr. Paulo Maiorka from University of Sao Paulo for their contribution in
our research.
Author details
Nelson F. Lizier, Irina Kerkis and Cristiane V. Wenceslau
Laboratory of Genetics, Butantan Institute and Department of Morphology and Genetics,
Federal University of Sao Paulo, Brazil
References
[1] Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilić J,
Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC. (2008) Efficient and
rapid generation of induced pluripotent stem cells from human keratinocytes. Nat
Biotechnol. Nov; 26(11):1276-84. Epub 2008 Oct 17.
[2] Amabile G, Meissner A. (2009) Induced pluripotent stem cells: current progress and
potential for regenerative medicine. Trends Mol Med. Feb; 15(2):59-68. Epub 2009 Jan
21.
[3] Banito A, Rashid ST, Acosta JC, Li S, Pereira CF, Geti I, Pinho S, Silva JC, Azuara V,
Walsh M, Vallier L, Gil J. (2009) Senescence impairs successful reprogramming to
pluripotent stem cells. Genes Dev. Sep 15; 23(18):2134-9. Epub 2009 Aug 20.
[4] Beltrão-Braga PC, Pignatari GC, Maiorka PC, Oliveira NA, Lizier NF, Wenceslau CV,
Miglino MA, Muotri AR, Kerkis I. (2011) Feeder-free derivation of induced pluripo‐
tent stem cells from human immature dental pulp stem cells. Cell Transplant.
[5] Bilic J, Izpisua Belmonte JC. (2012) Concise review: Induced pluripotent stem cells
versus embryonic stem cells: close enough or yet too far apart? Stem Cells. Jan; 30(1):
33-41.
[6] Caplan AI. (1991) Mesenchymal stem cells. J Orthop Res. Sep; 9(5):641-50.
[7] Cho YW, Hong T, Hong S, Guo H, Yu H, Kim D, Guszczynski T, Dressler GR, Cope‐
land TD, Kalkum M, Ge K. (2007) PTIP associates with MLL3- and MLL4-containing
histone H3 lysine 4 methyltransferase complex. J Biol Chem. Jul 13; 282(28):
20395-406. Epub 2007 May 11.
Generation of Induced Pluripotent Stem Cells from Dental Pulp Somatic Cells
http://dx.doi.org/10.5772/55856
145
[8] Conkright, M. D., Wani, M. A., Anderson, K. P., and Lingrel, J. B. (1999) A gene en‐
coding an intestinal-enriched member of the Krüppel-like factor family expressed in
intestinal epithelial cells. Nucleic Acids Res. 27, 1263–1270
[9] de Souza N. (2010) Primer: induced pluripotency. Nat Methods. Jan; 7(1):20-1.
[10] Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft
GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K. (2008) In‐
duced pluripotent stem cells generated from patients with ALS can be differentiated
into motor neurons. Science. Aug 29; 321(5893):1218-21.
[11] Dupin E, Calloni G, Real C, Gonçalves-Trentin A, Le Douarin NM. (2007) Neural
crest progenitors and stem cells. C R Biol. Jun-Jul; 330(6-7):521-9.
[12] Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN. (2009)
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. Jan
15; 457(7227):277-80. Epub 2008 Dec 21.
[13] Friedenstein AJ, Gorskaja JF, Kulagina NN. (1976) Fibroblast precursors in normal
and irradiated mouse hematopoietic organs. Exp Hematol. Sep; 4(5):267-74.
[14] Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. (2009) Efficient induction of
transgene-free human pluripotent stem cells using a vector based on Sendai virus, an
RNA virus that does not integrate into the host genome. Proc Jpn Acad 85: 348–362.
[15] Giordano G, La Monaca G, Annibali S, Cicconetti A, Ottolenghi L. (2011) Stem cells
from oral niches: a review. Ann Stomatol (Roma). Jan; 2(1-2):3-8. Epub 2011 Jul 18.
[16] Heng JC, Feng B, Han J, Jiang J, Kraus P, Ng JH, Orlov YL, Huss M, Yang L, Lufkin
T, Lim B, Ng HH. (2010) The nuclear receptor Nr5a2 can replace Oct4 in the reprog‐
ramming of murine somatic cells to pluripotent cells. Cell Stem Cell. Feb 5; 6(2):
167-74. Epub 2010 Jan 21.
[17] Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W,
Melton DA. (2008) Induction of pluripotent stem cells from primary human fibro‐
blasts with only Oct4 and Sox2. Nat Biotechnol. Nov; 26(11):1269-75.
[18] Ikeda E, Yagi K, Kojima M, Yagyuu T, Ohshima A, Sobajima S, Tadokoro M, Katsube
Y, Isoda K, Kondoh M, Kawase M, Go MJ, Adachi H, Yokota Y, Kirita T, Ohgushi H.
(2008) Multipotent cells from the human third molar: feasibility of cell-based therapy
for liver disease. Differentiation. May; 76(5):495-505.
[19] Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. (2009) Virus-free
induction of pluripotency and subsequent excision of reprogramming factors. Nature
458: 771–775.
[20] Kerkis I, Caplan AI. (2012) Stem cells in dental pulp of deciduous teeth. Tissue Eng
Part B Rev. Apr;18(2):129-38
[21] Kerkis I, Kerkis A, Dozortsev D, Stukart-Parsons GC, Gomes Massironi SM, Pereira
LV, Caplan AI, Cerruti HF (2006)Isolation and characterization of a population of im‐
Pluripotent Stem Cells146
mature dental pulp stem cells expressing OCT-4 and other embryonic stem cell
markers. Cells Tissues Organs; 184(3-4):105-16.
[22] Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY,
Lanza R, et al. (2009) Generation of human induced pluripotent stem cells by direct
delivery of reprogramming proteins. Cell Stem Cell 4: 472–476.
[23] Le Douarin NM, Brito JM, Creuzet S (2007) Role of the neural crest in face and brain
development. Brain Res Rev. Oct; 55(2):237-47.
[24] Le Douarin NM, Calloni GW, Dupin E (2008) The stem cells of the neural crest. Cell
Cycle 7: 1013–9.
[25] Le Douarin NM, Creuzet S, Dupin E (2004) Neural crest cell plasticity and its limits.
Development 131: 4637-50
[26] Le Douarin NM, Dupin E (2003) Multipotentiality of the neural crest. Curr Opin Gen‐
et Dev 13: 529–36.
[27] Le Douarin NM, Dupin E. (2012)The neural crest in vertebrate evolution. Curr Opin
Genet Dev. Jul 6. [Epub ahead of print]
[28] Lewitzky M, Yamanaka S. (2007) Reprogramming somatic cells towards pluripoten‐
cy by defined factors. Curr Opin Biotechnol. Oct; 18(5):467-73.
[29] Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao
E, Hayek A, et al. (2009) A chemical platform for improved induction of human
iPSCs. Nat Methods 6: 805–808.
[30] Liu SV (2008) iPS cells: a more critical review. Stem Cells Dev. Jun;17(3):391-7.
[31] Lizier NF, Kerkis A, Gomes CM, Hebling J, Oliveira CF, Caplan AI, Kerkis I (2012)
Scaling-up of dental pulp stem cells isolated from multiple niches. PLoS One;
7(6):e39885. Epub 2012 Jun 29.
[32] Maherali N, Hochedlinger K (2008) Induced pluripotency of mouse and human so‐
matic cells. Cold Spring Harb Symp Quant Biol. 8; 73:157-62.
[33] Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR. (2009)
Transcriptional signature and memory retention of human-induced pluripotent stem
cells. PLoS One. Sep 18; 4(9):e7076.
[34] McDevitt TC, Palecek SP (2008) Innovation in the culture and derivation of pluripo‐
tent human stem cells. Curr Opin Biotechnol. Oct; 19(5):527-33
[35] Miura, M., Gronthos, S., Zhao, M., Lu, B., Fisher, L.W., et al. (2003) SHED: Stem cells
from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 100, 5807.
[36] Muchkaeva IA, Dashinimaev EB, Terskikh VV, Sukhanov YV, Vasiliev AV (2012)
Molecular mechanisms of induced pluripotency. Acta Naturae. Jan; 4(1):12-22.
Generation of Induced Pluripotent Stem Cells from Dental Pulp Somatic Cells
http://dx.doi.org/10.5772/55856
147
[37] Murata K, Kouzarides T, Bannister AJ, Gurdon JB (2010) Histone H3 lysine 4 methyl‐
ation is associated with the transcriptional reprogramming efficiency of somatic nu‐
clei by oocytes. Epigenetics Chromatin. Feb 4; 3(1):4.
[38] Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mo‐
chiduki Y, Takizawa N, Yamanaka S (2008) Generation of induced pluripotent stem
cells without Myc from mouse and human fibroblasts. Nat Biotechnol. Jan; 26(1):
101-6. Epub 2007 Nov 30.
[39] Nakajima F, Tokunaga K, Nakatsuji N (2007) Human leukocyte antigen matching es‐
timations in a hypothetical bank of human embryonic stem cell lines in the Japanese
population for use in cell transplantation therapy. Stem Cells. Apr; 25(4):983-5. Epub
2006 Dec 21.
[40] Nakatsuji N, Nakajima F, Tokunaga K (2008) HLA-haplotype banking and iPS cells.
Nat Biotechnol. Jul; 26(7):739-40.
[41] Nishikawa S, Goldstein RA, Nierras CR (2008) The promise of human induced pluri‐
potent stem cells for research and therapy. Nat Rev Mol Cell Biol. Sep; 9(9):725-9.
[42] Oda Y, Yoshimura Y, Ohnishi H, Tadokoro M, Katsube Y, Sasao M, Kubo Y, Hattori
K, Saito S, Horimoto K, Yuba S, Ohgushi H (2010) Induction of pluripotent stem cells
from human third molar mesenchymal stromal cells. J Biol Chem. Sep 17; 285(38):
29270-8.
[43] Ohnuki M, Takahashi K, Yamanaka S (2009) Generation and characterization of hu‐
man induced pluripotent stem cells. Curr Protoc Stem Cell Biol. Jun; Chapter 4: Unit
4A.2.
[44] Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S (2008) Generation of
mouse induced pluripotent stem cells without viral vectors. Science. Nov 7;
322(5903):949-53. Epub 2008 Oct 9.
[45] Ooi L, Sidhu K, Poljak A, Sutherland G, O'Connor MD, Sachdev P, Münch G (2012)
Induced pluripotent stem cells as tools for disease modelling and drug discovery in
Alzheimer's disease. J Neural Transm. Jun 13.
[46] Patel SR, Kim D, Levitan I, Dressler GR (2007) The BRCT-domain containing protein
PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev Cell. Oct;
13(4):580-92.
[47] Shields, J. M., Christy, R. J., and Yang, V. W. (1996) Identification and characteriza‐
tion of a gene encoding a gut-enriched Krüppel-like factor expressed during growth
arrest. J. Biol. Chem. 271, 20009–20017.
[48] Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A,
Cooper O, Mitalipova M, Isacson O, Jaenisch R (2009) Parkinson's disease patient-de‐
rived induced pluripotent stem cells free of viral reprogramming factors. Cell. Mar 6;
136(5):964-77.
Pluripotent Stem Cells148
[49] Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K (2008) Induced pluripotent
stem cells generated without viral integration. Science 322: 945–949.
[50] Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S.
(2007) Induction of pluripotent stem cells from adult human fibroblasts by defined
factors. Cell 131: 861–872.
[51] Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse em‐
bryonic and adult fibroblast cultures by defined factors. Cell. 126(4): 663-76.
[52] Takeda T, Tezuka Y, Horiuchi M, Hosono K, Iida K, Hatakeyama D, Miyaki S, Kuni‐
sada T, Shibata T, Tezuka K. (2008) Characterization of dental pulp stem cells of hu‐
man tooth germs. J Dent Res. Jul; 87(7):676-81.
[53] Tamaoki N, Takahashi K, Tanaka T, Ichisaka T, Aoki H, Takeda-Kawaguchi T, Iida
K, Kunisada T, Shibata T, Yamanaka S, Tezuka K (2010) Dental pulp cells for induced
pluripotent stem cell banking. J Dent Res. Aug; 89(8):773-8.
[54] van Attikum H, Gasser SM (2009) Crosstalk between histone modifications during
the DNA damage response. Trends Cell Biol. May; 19(5):207-17. Review.
[55] Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, Cowling R,
Wang W, Liu P, Gertsenstein M, Stadtfeld and Hochedlinger et al. (2009) piggyBac trans‐
position reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766–770
[56] Yan, X., Qin, H., Qu, C., Tuan, R.S., Shi, S., and Huang, G.T (2010) iPS cell reprogram‐
med from human mesenchymal-like stem/progenitor cells of dental tissue origin.
Stem Cells Dev 19, 469.
[57] Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA (2009) Human in‐
duced pluripotent stem cells free of vector and transgene sequences. Science 324: 797–
801.
[58] Yu J, Thomson JA. (2008) Pluripotent stem cell lines. Genes Dev.; 22(15):1987-97.
[59] Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J,
Jonsdottir GA, Ruotti V, Stewart R, et al. (2007) Induced pluripotent stem cell lines
derived from human somatic cells. Science 318: 1917–1920.
[60] Yusa K, Rad R, Takeda J, Bradley A (2009) Generation of transgene-free induced plu‐
ripotent mouse stem cells by the piggyBac transposon. Nat Methods 6: 363–369.
[61] Zhao R, Daley GQ (2008) From fibroblasts to iPS cells: induced pluripotency by de‐
fined factors. J Cell Biochem.; 105(4): 949-55
[62] Zhou W, Freed CR (2009) Adenoviral gene delivery can reprogram human fibro‐
blasts to induced pluripotent stem cells. Stem Cells 27: 2667–2674.
[63] Zouboulis CC, Adjaye J, Akamatsu H, Moe-Behrens G, Niemann C (2008) Human
skin stem cells and the ageing process. Exp Gerontol. Nov; 43(11):986-97.
Generation of Induced Pluripotent Stem Cells from Dental Pulp Somatic Cells
http://dx.doi.org/10.5772/55856
149

